<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03632382</url>
  </required_header>
  <id_info>
    <org_study_id>38RC17.359</org_study_id>
    <nct_id>NCT03632382</nct_id>
  </id_info>
  <brief_title>Non-invasive Device for the Screening and Diagnosis of Sleep Apnea Syndrome</brief_title>
  <acronym>Episas</acronym>
  <official_title>Non-invasive Device for the Screening and Diagnosis of Sleep Apnea Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>SATT Linksium GRENOBLE</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ARTEHIS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ARCTIC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective study aims to establish and evaluate a predictive model to diagnose OSA with&#xD;
      maxillofacial characteristics 3D acquisition.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Polysomnography is the gold-standard for obstructive sleep apnea (OSA) diagnosis. However,&#xD;
      OSA is still undiagnosed. Maxillofacial profile can influence OSA severity. Morphological&#xD;
      characteristics can be identified but are not enough measurable and analysable by physicians.&#xD;
      3D acquisition of maxillofacial characteristics with a user-friendly tool, quick and&#xD;
      low-priced could be used to obtain a predictive model as an OSA risk indicator. Thus, the aim&#xD;
      of this study is to establish and evaluate a predictive model to diagnose OSA with&#xD;
      maxillofacial characteristics 3D acquisition.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 27, 2018</start_date>
  <completion_date type="Actual">September 8, 2020</completion_date>
  <primary_completion_date type="Actual">July 27, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Prospective</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Establish and evaluate a predictive model for OSA diagnosis by 3D acquisition of characteristics maxillofacial</measure>
    <time_frame>1 measure at inclusion</time_frame>
    <description>apnea hypopnea index will be measured by polysomnography for each patient and compared to a predictive model establish from body mass index and 3D acquisition (cricomental distance...)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity study from different stages of OSA severity</measure>
    <time_frame>1 measure at inclusion</time_frame>
    <description>OSA severity stages will be apnea hypopnea index &lt;5, &lt;10, &lt;15</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare diagnosis performances of predictive model and Berlin or NoSAS questionnaires</measure>
    <time_frame>1 measure at inclusion</time_frame>
    <description>Correlation between the Berlin or NoSAS score and the predictive model results</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate performances of the combination (Berlin questionnaire + predictive model) to estimate the OSA risk</measure>
    <time_frame>1 measure at inclusion</time_frame>
    <description>Calculate the sensitivity, specificity, predictive positive value and predictive negative value of the combination</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">280</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>OSA diagnosis with 3D acquisition</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>OSA diagnosis with 3D acquisition</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>3D acquisition of maxillofacial characteristics</intervention_name>
    <description>A 3D acquisition of maxillofacial characteristics will be performed for each patient in order to validate a predictive model comparable to data obtained by polysomnography</description>
    <arm_group_label>OSA diagnosis with 3D acquisition</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  BMI &lt; 35 kg/mÂ²&#xD;
&#xD;
          -  caucasian men&#xD;
&#xD;
          -  patients from the sleep laboratory (CHU Grenoble Alpes) admitted for a polysomnography&#xD;
&#xD;
          -  Patient who has given free and informed consent in writing&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of maxillofacial surgery&#xD;
&#xD;
          -  dental malocclusion&#xD;
&#xD;
          -  patient involved in another clinical research study&#xD;
&#xD;
          -  patient not affiliated with social security&#xD;
&#xD;
          -  patient deprived of liberty or hospitalized without consent&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Louis PEPIN</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Grenoble Alpes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Grenoble Alpes University Hospital</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>August 13, 2018</study_first_submitted>
  <study_first_submitted_qc>August 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2018</study_first_posted>
  <last_update_submitted>February 9, 2021</last_update_submitted>
  <last_update_submitted_qc>February 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sleep apnea diagnosis</keyword>
  <keyword>3D acquisition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

